These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 27708239)
1. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort. Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay. Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837 [TBL] [Abstract][Full Text] [Related]
3. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study. Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368 [TBL] [Abstract][Full Text] [Related]
4. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer. Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Gruvberger-Saal SK; Saal LH; Holm K; Hegardt C; Arason A; Fagerholm R; Persson C; Grabau D; Johnsson E; Lövgren K; Magnusson L; Heikkilä P; Agnarsson BA; Johannsson OT; Malmström P; Fernö M; Olsson H; Loman N; Nevanlinna H; Barkardottir RB; Borg Å Cancer Res; 2012 Aug; 72(16):4028-36. PubMed ID: 22706203 [TBL] [Abstract][Full Text] [Related]
5. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling. Wang J; Ray PS; Sim MS; Zhou XZ; Lu KP; Lee AV; Lin X; Bagaria SP; Giuliano AE; Cui X Oncogene; 2012 Nov; 31(45):4798-802. PubMed ID: 22249250 [TBL] [Abstract][Full Text] [Related]
6. BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers. Tkocz D; Crawford NT; Buckley NE; Berry FB; Kennedy RD; Gorski JJ; Harkin DP; Mullan PB Oncogene; 2012 Aug; 31(32):3667-78. PubMed ID: 22120723 [TBL] [Abstract][Full Text] [Related]
7. Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers. Yan M; Shield-Artin K; Byrne D; Deb S; Waddell N; ; Haviv I; Fox SB BMC Cancer; 2015 Jul; 15():506. PubMed ID: 26152113 [TBL] [Abstract][Full Text] [Related]
8. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer. Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer. Mott L; Su K; Pack DW Cancer Gene Ther; 2018 May; 25(3-4):84-91. PubMed ID: 29511313 [TBL] [Abstract][Full Text] [Related]
10. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer. Jin Y; Han B; Chen J; Wiedemeyer R; Orsulic S; Bose S; Zhang X; Karlan BY; Giuliano AE; Cui Y; Cui X Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S758-66. PubMed ID: 25124473 [TBL] [Abstract][Full Text] [Related]
11. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Ray PS; Wang J; Qu Y; Sim MS; Shamonki J; Bagaria SP; Ye X; Liu B; Elashoff D; Hoon DS; Walter MA; Martens JW; Richardson AL; Giuliano AE; Cui X Cancer Res; 2010 May; 70(10):3870-6. PubMed ID: 20406990 [TBL] [Abstract][Full Text] [Related]
12. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer. Liu J; Shen L; Yao J; Li Y; Wang Y; Chen H; Geng P Mol Med Rep; 2015 Apr; 11(4):3155-9. PubMed ID: 25516208 [TBL] [Abstract][Full Text] [Related]
13. FOXC1: an emerging marker and therapeutic target for cancer. Han B; Bhowmick N; Qu Y; Chung S; Giuliano AE; Cui X Oncogene; 2017 Jul; 36(28):3957-3963. PubMed ID: 28288141 [TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Pinilla SM; Honrado E; Hardisson D; Benítez J; Palacios J Breast Cancer Res Treat; 2006 Sep; 99(1):85-90. PubMed ID: 16541313 [TBL] [Abstract][Full Text] [Related]
15. The potential pathway of FOXC1 high expression in regulating the proliferation, migration, cell cycle and epithelialmesenchymal transition of basal-like breast cancer and in vivo imaging. Zuo H; Yang Q J BUON; 2018; 23(3):720-728. PubMed ID: 30003742 [TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women. Jing MX; Mao XY; Li C; Wei J; Liu C; Jin F Tumour Biol; 2011 Aug; 32(4):713-9. PubMed ID: 21625942 [TBL] [Abstract][Full Text] [Related]
18. The role and the potential regulatory pathways of high expression of forkhead box C1 in promoting tumor growth and metastasis of basal-like breast cancer. Zuo HD; Wu Yao W J BUON; 2016; 21(4):818-825. PubMed ID: 27685901 [TBL] [Abstract][Full Text] [Related]
19. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance. Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579 [TBL] [Abstract][Full Text] [Related]
20. p16INK4a expression in basal-like breast carcinoma. Bohn OL; Fuertes-Camilo M; Navarro L; Saldivar J; Sanchez-Sosa S Int J Clin Exp Pathol; 2010 Jun; 3(6):600-7. PubMed ID: 20661408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]